Come up with a name for your new list and we'll add to it:
Motif BioSciences raised a round of funding on April 06, 2007. Investors include
Amphion Innovations PLC..
Motif BioSciences is developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. Motif has a lead antibiotic candidat…